To improve the sensitivity of the radioimmunoassay method for anti-AChR-antibody, large amounts of sera from patients with myasthenia gravis, and higher concentrations of antigens and rabbit anti-human-IgG-antiserum, were used. These procedures enabled measurement of the titre value of over 0.04 pmo
Ocular myasthenia gravis secondary to thymoma
โ Scribed by Robert C. Capone; Michelle R. Trump; Richard M. Frankel; Kathryn B. Miller
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 757 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0953-4431
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Malignant thymoma (MT) is a rare tumor that is often associated with myasthenia gravis (MG). This tumor is considered resistant to chemotherapy. We had the opportunity to treat five patients with MT with cyclophosphamide 800 mg/m2, Adriamycin 50 mg/m2, and vincristine 1.4 mg/m2 (CAV) in cycles of 21
Myasthenia gravis (MG) occurs in up to 44% of patients with thymoma; one-third of neoplasms are invasive at surgery {I}, and 1 to 15% show extrathoracic metastases [2}. The prognosis in patients having MG with invasive thymoma is worse. Thymectomy and radiotherapy are the mainstays of treatment for